Skip to content

The effect of fentanyl on headache after cesarean section

Investigation of the intrathecal fentanyl effect on post spinal anesthesia headache in patients undergoing elective cesarean section

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170515033986N3
Enrollment
56
Registered
2022-01-30
Start date
2021-11-22
Completion date
Unknown
Last updated
2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Headache after cesarean section. Other headache syndromes

Interventions

Intervention 1: Intervention group: The spinal anesthesia will be performed using hyperbaric bupivacaine 0.5% (2.5 ml) and 25 micrograms of fentanyl (0.5 ml). Fentanyl is a product of Caspian Pharmac

Sponsors

Oroumia University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 35 Years

Inclusion criteria

Inclusion criteria: Women undergoing elective cesarean section under spinal anesthesia Women aged 15 to 35 years Patients with class ASA I and ASA II

Exclusion criteria

Exclusion criteria: Any contraindication for spinal anesthesia A history of migraine or chronic headache Mental diseases Neurological diseases Epilepsy Coagulation disorders Drug abusers Eclampsia and preeclampsia during pregnancy

Design outcomes

Primary

MeasureTime frame
Frequency of headaches. Timepoint: In recovery, 6, 12 and 24 hours after surgery. Method of measurement: self-reporting.;The severity of the headache. Timepoint: In recovery, 6, 12 and 24 hours after surgery. Method of measurement: Verbal Rating Scale (VRS).

Secondary

MeasureTime frame
Mean arterial blood pressure. Timepoint: In recovery, 6, 12 and 24 hours after surgery. Method of measurement: Monitoring.;Heart rate. Timepoint: In recovery, 6, 12 and 24 hours after surgery. Method of measurement: Monitoring.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Nazli Karami

Oroumia University of Medical Sciences

karami.n@umsu.ac.ir+98 44 3198 8293

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026